HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Infantile epileptic spasms syndrome — Clinical Guidelines

Overview

Infantile epileptic spasms syndrome (IESS), also known as West syndrome, is characterized by clusters of sudden, brief, involuntary muscle contractions in infants typically under one year of age, often accompanied by developmental regression and a specific EEG pattern called hypsarrhythmia 1 7.

Diagnosis

Clinical presentation: Clusters of epileptic spasms, developmental arrest or regression 7.

EEG findings: Hypsarrhythmia, a chaotic pattern with high voltage and slow waves 7.

Exclusion of other causes: Rule out metabolic disorders, structural brain abnormalities, and other epileptic encephalopathies 6 7.

Management

First-line treatments:

- Adrenocorticotropic hormone (ACTH): Commonly used, though comparative efficacy with prednisolone is debated 1 2. - Prednisolone: Alternative first-line therapy with ongoing controversy regarding its efficacy compared to ACTH 1. - Vigabatrin: Recommended as a first-line treatment alongside ACTH 2 8.

Adjunctive treatments:

- If initial treatments fail, consider second-line therapies such as valproate, topiramate, or other anticonvulsants 8. - High-dose pyridoxine (vitamin B6): Reported efficacy in specific cases 10.

Special Populations

Infants with periventricular leukomalacia (PVL): ACTH monotherapy may be considered, though long-term outcomes require further study 2.

Genetic causes: Whole-exome sequencing can improve diagnostic yield in cases with unknown etiology 6.

Key Recommendations

Initiate first-line treatment with ACTH or prednisolone for infantile epileptic spasms syndrome (Evidence: Moderate 1).

Vigabatrin should be considered as part of first-line therapy, especially when used concurrently with ACTH (Evidence: Moderate 2 8).

In cases refractory to initial treatments, evaluate and consider second-line anticonvulsants like valproate or topiramate (Evidence: Expert opinion).

For infants with PVL, ACTH monotherapy can be attempted, though long-term outcomes need further investigation (Evidence: Weak 2).

Utilize whole-exome sequencing in cases where a genetic cause is suspected but not identified to enhance diagnostic accuracy (Evidence: Moderate 6).

References

1 Gao R, Cheng X, Huang L, Luo R, Zeng L, Cheng G et al.. Adrenocorticotropic Hormone versus Prednisolone for Infantile Epileptic Spasms Syndrome: A Systematic Review and Economic Evaluation. Neuropediatrics 2025. link 2 Matsuura R, Hamano SI, Hirata Y, Takeda R, Takeuchi H, Koichihara R et al.. Long-term analysis of adrenocorticotropic hormone monotherapy for infantile epileptic spasms syndrome with periventricular leukomalacia. Seizure 2023. link 3 Sánchez Fernández I, Amengual-Gual M, Barcia Aguilar C, Romeu A, Sheikh T, Torres A et al.. Temporal trends in the cost and use of first-line treatments for infantile epileptic spasms syndrome. Epilepsia 2023. link 4 Goraya JS, Kaur A, Setia S. Epileptic Spasms During Recovery From Nutritional Infantile Vitamin B. Pediatric neurology 2023. link 5 Jain P, Sahu JK, Horn PS, Chau V, Go C, Mahood Q et al.. Treatment of children with infantile spasms: A network meta-analysis. Developmental medicine and child neurology 2022. link 6 Dimassi S, Labalme A, Ville D, Calender A, Mignot C, Boutry-Kryza N et al.. Whole-exome sequencing improves the diagnosis yield in sporadic infantile spasm syndrome. Clinical genetics 2016. link 7 Boutry-Kryza N, Labalme A, Ville D, de Bellescize J, Touraine R, Prieur F et al.. Molecular characterization of a cohort of 73 patients with infantile spasms syndrome. European journal of medical genetics 2015. link 8 Chiron C, Dulac O. Drug therapy for West's syndrome. Advances in experimental medicine and biology 2002. link 9 Veneselli E, Perrone MV, Di Rocco M, Gaggero R, Biancheri R. Malignant migrating partial seizures in infancy. Epilepsy research 2001. link00197-8) 10 Blennow G, Starck L. High dose B6 treatment in infantile spasms. Neuropediatrics 1986. link 11 Tjiam AT, Stefanko S, Schenk VW, de Vlieger M. Infantile spasms associated with hemihypsarrhythmia and hemimegalencephaly. Developmental medicine and child neurology 1978. link

Infantile epileptic spasms syndrome